NCT05339139 - SAfety of Regional Citrate Anticoagulation (SARCA Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions

Acute Kidney InjuryESRD

Interventions

COMBINATION_PRODUCT

Dialysis

In this study critically ill adult patients requiring Continuous Renal Replacement Therapy (CRRT) will receive Regional Citrate Anticoagulation (CRA) which will be delivered by multiFiltratePRO system.

Trial Locations (10)

32803

NOT_YET_RECRUITING

Advent Health Orlando, Orlando

39350

RECRUITING

University of Mississippi Medical Center, Jackson

48202

RECRUITING

Henry Ford Hospital, Detroit

55905

COMPLETED

Mayo Clinic, Rochester

63110

COMPLETED

Washington University - Hospital, St Louis

72205

COMPLETED

John L. McClellan Memorial Veterans' Hospital, Little Rock

RECRUITING

University of Arkansas for Medical Sciences (UAMS), Little Rock

84107

RECRUITING

Intermountain Health, Murray

01655

RECRUITING

UMass Memorial Medical Center, Worcester

48109-5000

COMPLETED

University of Michigan, Ann Arbor

All Listed Sponsors

lead

Fresenius Medical Care North America

INDUSTRY